» Articles » PMID: 28592916

A Reduction in Selenoprotein S Amplifies the Inflammatory Profile of Fast-Twitch Skeletal Muscle in the Dystrophic Mouse

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2017 Jun 9
PMID 28592916
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Excessive inflammation is a hallmark of muscle myopathies, including Duchenne muscular dystrophy (DMD). There is interest in characterising novel genes that regulate inflammation due to their potential to modify disease progression. Gene polymorphisms in () are associated with elevated proinflammatory cytokines, and in vitro SEPS1 is protective against inflammatory stress. Given that SEPS1 is highly expressed in skeletal muscle, we investigated whether the genetic reduction of exacerbated inflammation in the mouse. F1 male mice with a heterozygous deletion (:) were generated. The mice had a 50% reduction in SEPS1 protein expression in hindlimb muscles. In the extensor digitorum longus (EDL) muscles, mRNA expression of () ( = 0.034), macrophage marker ( = 0.030), and () ( = 0.056) were increased in mice. This was associated with a reduction in muscle fibre size; however, ex vivo EDL muscle strength and endurance were unaltered. In dystrophic slow twitch soleus muscles, SEPS1 reduction had no effect on the inflammatory profile nor function. In conclusion, the genetic reduction of appears to specifically exacerbate the inflammatory profile of fast-twitch muscle fibres, which are typically more vulnerable to degeneration in dystrophy.

Citing Articles

Impaired Upper Airway Muscle Function with Excessive or Deficient Dietary Intake of Selenium in Rats.

Burns D, Drummond S, Wolfel S, Murphy K, Szpunar J, OHalloran K Antioxidants (Basel). 2024; 13(9).

PMID: 39334739 PMC: 11429047. DOI: 10.3390/antiox13091080.


Current views on selenoprotein S in the pathophysiological processes of diabetes-induced atherosclerosis: potential therapeutics and underlying biomarkers.

Yu S, Du J Diabetol Metab Syndr. 2024; 16(1):5.

PMID: 38172976 PMC: 10763436. DOI: 10.1186/s13098-023-01247-y.


Identification of quantitative polymerase chain reaction reference genes suitable for normalising gene expression in the brain of normal and dystrophic mice and dogs.

Crawford A, Hildyard J, Wells D, Piercy R Wellcome Open Res. 2023; 6:84.

PMID: 37942409 PMC: 10628364. DOI: 10.12688/wellcomeopenres.16707.2.


Selenoprotein S: A versatile disordered protein.

Ghelichkhani F, Gonzalez F, Kapitonova M, Schaefer-Ramadan S, Liu J, Cheng R Arch Biochem Biophys. 2022; 731:109427.

PMID: 36241082 PMC: 10026367. DOI: 10.1016/j.abb.2022.109427.


β-Dystroglycan Restoration and Pathology Progression in the Dystrophic Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation.

Mantuano P, Boccanegra B, Conte E, De Bellis M, Cirmi S, Sanarica F Biomolecules. 2021; 11(11).

PMID: 34827740 PMC: 8615430. DOI: 10.3390/biom11111742.


References
1.
Pegoraro E, Hoffman E, Piva L, Gavassini B, Cagnin S, Ermani M . SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy. Neurology. 2010; 76(3):219-26. PMC: 3034396. DOI: 10.1212/WNL.0b013e318207afeb. View

2.
Taylor C, Colgan S . Hypoxia and gastrointestinal disease. J Mol Med (Berl). 2007; 85(12):1295-300. DOI: 10.1007/s00109-007-0277-z. View

3.
Martinez F, Gordon S . The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014; 6:13. PMC: 3944738. DOI: 10.12703/P6-13. View

4.
Yamazaki M, Minota S, Sakurai H, Miyazono K, Yamada A, Kanazawa I . Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy. Am J Pathol. 1994; 144(2):221-6. PMC: 1887141. View

5.
Mojumdar K, Liang F, Giordano C, Lemaire C, Danialou G, Okazaki T . Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2. EMBO Mol Med. 2014; 6(11):1476-92. PMC: 4237472. DOI: 10.15252/emmm.201403967. View